Etisalat fires warning shot to operators

first_img Operators admit big change needed for IoT success AddThis Sharing ButtonsShare to LinkedInLinkedInLinkedInShare to TwitterTwitterTwitterShare to FacebookFacebookFacebookShare to MoreAddThisMore 17 OCT 2016 LIVE FROM GSMA MOBILE 360 MIDDLE EAST: Operators are no longer the “cash cow” that governments and the media believe, insisted Hatem Dowidar, CEO, international operations, Etisalat, as he slammed the industry for failing to grow in the technology value chain.In an honest overview of the mobile players’ current status, speaking in a keynote speech at Mobile 360 Middle East in Dubai, Dowidar hit out at a common misconception that being an operator was “fancy”, and they were “having a great time”, given the amount of money generated.Accusing government of “milking” operators because of this, through taxes, spectrum prices and excise duties, among other fees, Dowidar revealed, out of the 18 countries Etisalat operates in, it is only generating “real profit” in four.This, however, doesn’t mean it could stop investing and, citing analysts that estimate a $1.7 trillion capex spend on mobile networks and fixed infrastructure over the next five years, he suggested the situation could get worse, unless operators begin to evolve beyond pure connectivity.“The big investment is not creating the returns we would hope for, or that we would like to see,” he said. “We want to be more than just a pipe. In the new world we want to be a hub of it all. We hope we are a bigger part of the value chain.”Apple comparisonCommenting on Apple’s evolution from hardware, to software, services and even payments, Dowidar said operators had “failed to grow in the value chain”, in the same way, while urging mobile operators to stop focusing competition on each other, and look at new competitors that were emerging.He also had a few choice words for regulators.“In the new world we are not only competing with the operators in the same regions, we are competing with Amazon, Google, their cloud services, IoT platforms and other applications,” he said. “This is a message to regulators to be open minded about what you allow the operators to do. Today we are smothering the operators’ capabilities to compete.” Kavit Majithia Author Related Kavit joined Mobile World Live in May 2015 as Content Editor. He started his journalism career at the Press Association before joining Euromoney’s graduate scheme in April 2010. Read More >> Read more center_img HomeM360 2016 Middle East Articles Etisalat fires warning shot to operators M360 2016 Middle East Articles Previous ArticleOnePlus CEO out to change shopping behaviourNext ArticleEgyptian operators now on board for 4G licences Tags Etisalatlast_img read more

More Lemon Less sugar? Let’s make a Lemonade!

first_imgWe cannot always be motivational,follow the rules, behave like a leader, make everyone laugh,make everyone fall in love with, and pose like an aristocrat.I know, sometimes;Life is more lemon’s less sugar.As they say “When life gives you lemon’s, enjoy the lemonade”and, while you are doing that for most of the time, most of your lifeYou actually forgot to live for yourself!So,Let’s thumbs up for the person you were,To the person, you are right now& To the person, you’ll become.Because The next time when you get bored having a lemonade each timeYou can still return to the home that you had made within yourselfAnd, have something better & tastierlast_img read more

ASP Scan (Weekly) for Feb 15, 2019

first_imgDigital stewardship cuts antibiotics for respiratory infections in UK studyElectronically delivered prescribing feedback and decision support interventions reduced antibiotic prescribing for respiratory infection (RTI) in adults by 12%, according to the results of a clinical trial published this week in the British Medical Journal.In the open label cluster randomized controlled trial, British researchers evaluated the impact of a 12-month antimicrobial stewardship intervention that included a brief training webinar, automated monthly feedback reports of antibiotic prescribing sent by email, and electronic decision support tools to inform clinicians when an antibiotic is indicated. Intervention components were supported by a local practice champion. The primary outcome was the rate of antibiotic prescriptions for respiratory tract infection (RTI) per 1,000 patient years.The trial included 79 general practices across the United Kingdom; 41 practices were in the stewardship arm, and 38 were in the usual-care arm. The overall adjusted rate ratio for antibiotic prescribing for RTI was 0.88 (95% confidence interval [CI], 0.78 to 0.99, P = 0.04), with prescribing rates of 98.7 per 1,000 patient years in the stewardship group (31,907 prescriptions) and 107.6 per 1,000 patient years for usual care (27,923 prescriptions).Results of the subgroup analysis showed that the intervention had the greatest impact on prescribing for adults aged 15 to 84 (adjusted rate ratio, 0.84; 95% CI, 0.75 to 0.95), with one antibiotic prescription per year avoided for every 62 patients (95% CI, 40 to 200). But there was no evidence of an effect for children under 15 (adjusted rate ratio, 0.96; 95% CI, 0.82 to 1.12) or adults over 85 (adjusted rate ratio, .97; 95% CI, 0.79 to 1.18). There was also no evidence of an increase in serious bacterial complications in the stewardship arm (rate ratio, 0.92; 95% CI, 0.74 to 1.13).”Although the absolute impact is moderate, it is likely to be important for public health in the drive to reduce antibiotic prescribing and the risks of antimicrobial resistance,” the authors of the study concluded. “Interventions using data from electronic health records might be used to promote antimicrobial stewardship in primary care and might be readily scaled up. The needs of very young or old patients need specific consideration.” Feb 13 BMJ study Cephalosporin resistance may raise risk of recurrent UTIsIn a retrospective cohort study yesterday in BMC Infectious Diseases, researchers with the University of Pennsylvania Perelman School of Medicine reported that extended-spectrum cephalosporin (ESC) resistance in community-onset urinary tract infection (UTI) caused by Enterobacteriaceae (EB) is significantly associated with increased risk of recurrent UTI within 12 months compared with ESC-susceptible EB.The researchers evaluated all patients presenting to emergency departments or outpatient practices within the University of Pennsylvania Health System from December 2010 through April 2013. Exposed patients were defined as those with an EB UTI demonstrating resistance to an ESC, and unexposed patients were those who had a UTI with ESC-susceptible EB. The primary outcome was time to first recurrent UTI.A total of 302 patients with an index community-onset EB UTI were included, with 151 exposed and 151 unexposed. Overall, 163 (54%) patients experienced a recurrent UTI with a median time to recurrence of 69 days (interquartile range, 25 to 183). On multivariable analyses, ESC-resistance was associated with an increased hazard of recurrent UTI (adjusted hazard ratio [aHR], 1.39, 95% confidence interval [CI], 1.01 to 1.91, P = 0.04). Other variables that were independently associated with recurrence included a history of UTI 6 months prior to the index UTI (aHR, 1.59; 95% CI, 1.17 to 2.15, P < 0.01) and presence of a urinary catheter at the time of the index UTI (aHR 1.59; 95% CI, 1.06 to 2.38, P = 0.03).Secondarily, the researchers found that when the treatment for the index UTI was adjusted for initial inappropriate antibiotic therapy, there was no longer a significant association between ESC-resistance and time to recurrent UTI (aHR 1.26; 95% CI, 0.91 to 1.76, P = 0.17), suggesting that the increased risk of recurrence with an ESC-resistant EB UTI could be related to the timing and selection of the treatment regimen.The researchers say further studies are needed to determine interventions that may reduce the risk of recurrence, including different antibiotic regimens and durations.Feb 14 BMC Infect Dis study Survey highlights room for improvement in pediatric C diff testingThe results of an electronic survey sent to pediatric infectious disease (PID) members of the Infectious Diseases Society of America's (IDSA's) Emerging Infections Network suggest there are opportunities to improve Clostridioides difficile infection (CDI) diagnostic stewardship practices in children. The findings appear today in Infection Control and Hospital Epidemiology.The objective of the survey was to determine the prevalence of CDI diagnostic practices in the United States as they relate to avoiding detection of asymptomatic C difficile carriage in children. Misclassification of asymptomatic carriers as having CDI can lead to unnecessary CDI antibiotic therapy and inaccurate CDI surveillance. One particular concern is the use of nucleic acid amplification tests (NAATs) without additional toxin testing. NAATs can detect C difficile strains that have the potential to produce toxins, but do not detect secreted toxins in the stool and therefore have poor diagnostic predictive value for CDI. Another is unnecessary testing in infants and young children, who have a low likelihood of CDI.Among 345 eligible respondents, 196 (57%) responded; 162 of these (83%) were aware of their institutional policies for CDI testing and management, and 159 (98%) respondents knew their institution’s C difficile testing method. Among these respondents, 99 (62%) said they use NAAT without toxin testing and 60 (38%) use toxin testing, either as a single test or a multistep algorithm.Of 153 respondents aware of symptom-based restrictions on C difficile testing, 10 (7%) reported that formed stools were tested for C difficile at their institution, and 76 of 151 (50%) respondents who were aware of age-based restrictions on testing reported that their institution does not restrict testing in infants and young children. The frequency of symptom- and age-based testing restrictions did not vary between institutions using NAAT alone compared with those using toxin testing for C difficile diagnosis. Of 143 respondents at institutions with neonatal intensive care units (NICUs), 26 (16%) permit testing of NICU patients and 12 of 26 (46%) treat CDI with antibiotics in this patient population.The survey data were gathered shortly before publication of updated clinical practice guidelines for CDI from IDSA and the Society for Healthcare Epidemiology of America (SHEA), which include recommendations to limit testing in pediatric patients with low likelihood of CDI and to avoid detection of asymptomatic carriage.The authors of the study conclude, "In summary, these data suggest that there are pervasive opportunities to improve CDI diagnostic stewardship practices in children and to develop institutional policies to align with recently updated IDSA/SHEA guidance, particularly in hospitals using NAATs alone for CDI diagnosis in children."Feb 15 Infect Control Hosp Epidemiol abstract Survey finds low postgrad stewardship training in pharmacists, nursesOriginally published by CIDRAP News Feb 14British investigators conducted an international survey and found that postgraduate training and support in antibiotic prescribing remain low among nurses and pharmacists, and, although antibiotic policies and committees are established in most institutions, surveillance of antibiotic use is not, according to a new report in Antimicrobial Resistance & Infection Control.The authors polled 505 professionals who had taken a Massive Online Open Course (MOOC) on antibiotic stewardship. Their aim was to assess their organizations' resources for antimicrobial stewardship. Of the respondents, 36% were physicians, 26% pharmacists, 18% nurses, and 20% other professions.Post-graduate training in infection management and stewardship was reported by 56% of physicians, 43% of nurses, and 35% of pharmacists. The researchers also found that 65% of primary care centers had antibiotic policies, compared with 83% of teaching hospitals and 79% of regional hospitals.Fifty-eight percent of teaching hospitals and 62% of regional hospitals reported a surveillance mechanism for antibiotic consumption. Respondents identified antimicrobial resistance, patient needs, policy, peer influence, and specialty-level culture and practices as important determinants for stewardship decision-making.Feb 12 Antimicrob Resist Infect Control study Use of antibiotics to promote growth in food animals down, OIE report saysOriginally published by CIDRAP News Feb 14The use of antimicrobials for growth promotion in food animals worldwide is down, and more nations are reporting specific data on the use of the drugs in livestock, according to the World Organization for Animal Health's (OIE's) third annual report on antimicrobial agents in animals, published today.A total of 110 countries of 155 surveyed (71%) did not use any antimicrobial drugs for growth promotion as of 2017, which is up from 86 of 146 (59%) reported in the second annual report, published in 2017. Of the 45 countries that used antimicrobials to promote growth, according to today's report, 18 (40%) had a regulatory framework that either provided a list of antimicrobials that can be used as growth promoters or provided a list of those that should not be used as growth promoters.In addition, today's report noted that 118 nations of 155 (76%) reported quantitative data for one or more years from 2015 to 2017, up slightly from 107 of 146 countries (73%) in the 2017 report. In the OIE's first such report, published in 2016, the rate was 89 of 130 nations (68%).The authors of the report conclude, "The OIE remains strongly committed to supporting our Members in developing robust measurement and transparent reporting mechanisms for antimicrobial use, but the challenges for many of our Members must not be under-estimated."Feb 14 OIE report Dental antibiotic stewardship program shows promising resultsOriginally published by CIDRAP News Feb 13A team of dentists, pharmacists, and physicians at the University of Illinois reported today in Open Forum Infectious Diseases that implementation of a comprehensive antibiotic stewardship intervention in a dental practice was associated with a significant improvement in antibiotic prescribing.After conducting a baseline needs assessment and literature evaluation to identify opportunities to improve antibiotic prescribing, faculty from the University of Illinois at Chicago (UIC) College of Dentistry, UIC College of Pharmacy, and the University of Illinois Hospital and Health Sciences System devised and implemented a multimodal intervention that focused on antibiotic use for acute oral infections, a common condition in the UIC dental clinic.The intervention, which is consistent with the Centers for Disease Control and Prevention's (CDC's) Core Elements of Outpatient Antibiotic Stewardship, included patient and provider education, clinical guideline development, and an assessment of the antibiotic prescribing rate per urgent care visit before and after the educational intervention.The results of the assessment showed that, among all providers in the practice, the antibiotic prescribing rate per urgent care visit decreased by 72.9% before and after the multimodal intervention (pre-intervention urgent care prescribing rate [September 2017], 8.5% [24/283]; post-intervention [May 2018], 2.3% [8/352], P < 0.001). Clinical providers also reported that they had become more conscious of appropriate prescribing since implementation of the educational guidelines.The authors of the study say the results suggest that simple educational interventions may decrease antibiotic prescribing in the dental setting, which accounts for 10% of all outpatient prescribing, and may be adapted to other dental practices.Feb 13 Open Forum Infect Dis abstract Study weighs value of antibiotics for resistant Staph in pandemic settingsOriginally published by CIDRAP News Feb 13An effective antibiotic that can treat secondary Staphylococcus aureus infections in a pandemic flu outbreak is worth more than $3 billion, according to a new study by researchers from the Center for Disease Dynamics, Economics, and Policy (CDDEP) and their colleagues in Scotland and the Netherlands.Writing in Health Economics, the authors said though antibiotic reserves are part of pandemic preparedness plans, experts haven't explores the value of stockpiling or conserving the effectiveness of antibiotics, despite the high morbidity of secondary bacterial infections and the growing ineffectiveness of antibiotics because of emerging antibiotic-resistant organisms.Using a mathematical framework based on UK preparedness plan assumptions the scientists estimated the value of investing in developing and conserving an antibiotic to lessen the burden of bacterial infections from resistant S aureus during a pandemic flu outbreak.The team found that the value of withholding an effective new oral antibiotic can be positive and significant unless the pandemic is mild, with few secondary illnesses involving the resistant strain or if most patients can be treated intravenously.Ramanan Laxminarayan, PhD, MPH, CDDEP director and the study's senior author, said in a CDDEP press release that secondary bacterial infections are a major cause of death and disability with flu, and antibiotic resistance is a major barrier to treating those infections. "This study shows that the value of an effective antibiotic against Staph infections, as an insurance policy against future pandemics, is between $3 [billion] and 4 billion at baseline," he said.Feb 11 Health Econ abstractFeb 12 CDDEP press release Study: Hospital readmission for Staph bacteremia patients common, costlyOriginally published by CIDRAP News Feb 12New research by scientists with the University of Mississippi Medical Center indicates that 30-day hospital readmission among patients who survived initial hospitalization with S aureus bloodstream infections is common and costly. The findings appeared yesterday in Clinical Infectious Diseases.Using the 2014 Nationwide Readmissions Database, the researchers examined 30-day readmission, mortality, length of stay, and costs associated with initial hospitalization for methicillin-susceptible and methicillin-resistant S aureus (MSSA and MRSA) bacteremia. Although research on mortality from S aureus bacteremia is extensive, less is known about hospital readmission, and greater understanding of readmission, and its risk factors, could result in improved patient care.From January 2014 through November 2014, the researchers identified 92,089 patients with S aureus bacteremia, 48.5% of whom had MRSA bacteremia. The all-cause 30-day readmission rate was 22% overall, with no significant difference between MRSA and MSSA cases. But patients with MRSA bacteremia were 17% more likely to have 30-day readmission with S aureus bacteremia recurrence (hazard ratio, 1.17; 95% confidence interval [CI], 1.02 to 1.35). In addition, patients with MRSA bacteremia had higher in-hospital mortality (odds ratio,1.15; 95% CI, 1.07 to 1.22), and longer hospital stays (incidence rate ratio, 1.08; 95% CI, 1.06 to 1.11).Readmission with bacteremia recurrence was particularly associated with endocarditis, congestive heart failure, end stage renal failure, underlying immunocompromising comorbidities, and drug abuse. The mean overall cost of readmission was $12,425 per patient, and $19,186 per patient in those with bacteremia recurrence.The authors of the study conclude, "Efforts should continue to optimize patient care, particularly for those with risk factors for readmission, to decrease readmissions and associated morbidity and mortality in the context of S aureus bacteremia." Feb 11 Clin Infect Dis abstract Review of hospital stewardship programs finds economic impactsOriginally published by CIDRAP News Feb 12A systematic review of previous research suggests that hospital antimicrobial stewardship programs (ASPs) help save costs by decreasing length of stay and antibiotic expenditures.The review, published today in Antimicrobial Resistance and Infection Control, looked at studies published from 2000 through 2017 that evaluated patient and/or economic outcomes after implementation of hospital ASPs. Key economic outcomes were costs associated with antibiotics, length of stay, and total costs (including operation and implementation). A total of 146 primary research studies were included on the final analysis, the majority of which were conducted in 500-1,000 bed hospitals in North America (49%), Europe (25%), and Asia (14%).Of the studies that evaluated length of stay and antibiotic expenditure, 85% (58 of 68 studies) showed a reduction in length of stay and 92% (80 of 87 studies) showed a decrease in antimicrobial costs following ASP implementation. Average cost savings were $732 per patient in US studies and €198 per patient ($224 US) in European studies, with length of stay being a key driver of cost savings. Savings were higher among hospitals with ASPs that included therapy review and antibiotic restrictions."Overall, this systematic review demonstrates that ASPs can offset or reduce costs while improving some patient outcomes, thereby suggesting high value for certain healthcare systems," the authors of the review write. "However, for the findings to be globally relevant, more studies, particularly in real world settings across a diverse range of geographies and resource settings are required, so that a full critical appraisal of the true value of these programs can be made."Feb 12 Antimicrob Resist Infect Control study Fleming Fund selects UK partners for African stewardship programOriginally published by CIDRAP News Feb 12The Fleming Fund, a UK government aid program to help low- and middle-income countries fight antimicrobial resistance (AMR), today announced the 12 hospitals and research institutions that will work with partners in four African countries to promote antimicrobial stewardship.Through the Commonwealth Partnerships for Antimicrobial Stewardship program, clinicians, nurses and pharmacists from 12 National Health Service (NHS) trusts and UK academic institutions will work with partner teams in hospitals in Ghana, Tanzania, Uganda, and Zambia to improve stewardship practices and protocols and develop tools that help reduce the spread of AMR. The winners were chosen for their strong records in antimicrobial stewardship."The quality of all the proposals received was extremely high and the selected NHS teams will make a great impact working in partnership with teams on stewardship practices across Africa," Keith Ridge, England's Chief Pharmaceutical Officer, said in a press release.The Fleming Fund will provide £1.3 million ($1.68 million US) to support the projects, which will last up to 15 months. Feb 12 Fleming Fund press release CDC: 19 states may have raw milk exposure to drug-resistant BrucellaOriginally published by CIDRAP News Feb 11Today the CDC announced that health workers are investigating potential exposures to a drug-resistant Brucella strain RB51 in 19 states. The strain comes from raw (unpasteurized) milk from Miller's Biodiversity Farm in Quarryville, Penn."One case of RB51 infection (brucellosis) has been confirmed in New York, and an unknown number of people may have been exposed to RB51 from drinking the milk from this farm," the CDC said. "This type of Brucella is resistant to first-line drugs and can be difficult to diagnose because of limited testing options and the fact that early brucellosis symptoms are similar to those of more common illnesses like flu.­"In November of 2018, a New York resident became the third American to be diagnosed as having brucellosis caused by the RB51 strain. Two cases (unrelated to the Quarryville farm) were also reported in 2017, in New Jersey and Texas.The 19 states in question are Alabama, California, Connecticut, Florida, Georgia, Iowa, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, New Jersey, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, and Virginia.The CDC said anyone who has consumed raw milk from the farm between January of 2016 and January 2019 may have been exposed to the strain. Feb 8 CDC alert Study: MDROs prevalent in California nursing homes, long-term acute careOriginally published by CIDRAP News Feb 11A team of researchers studying nursing homes and long-term acute care facilities in southern California reported today in Clinical Infectious Diseases that a large majority of residents and patients in these facilities harbor multidrug-resistant organisms (MDROs).The one-day point prevalence study was conducted by researchers with the Shared Health Intervention to Eliminate Life-Threatening Dissemination of MDROs in Orange County (SHIELD OC), a regional public health collaborative to measure the impacts of a coordinated infection prevention initiative on MDRO carriage and infection at 18 nursing homes (NHs), 17 short term acute care hospitals, and 3 long term acute care facilities (LTACs). The aim was to establish baseline MDRO prevalence in the NH and LTACS settings, as patients and residents in these facilities are transferred frequently and are known to serve as a source of MDRO transmission.From September 2016 to March 2017, a random sampling of 1,050 patients from the 21 facilities were screened for MRSA, vancomycin-resistance Enterococcus spp. (VRE), extended-spectrum beta-lactamase producing organisms (ESBL), and carbapenem-resistant Enterobacteriaceae (CRE) using nares, axilla/groin, and peri-rectal swabs. In addition, researchers performed multivariate analyses of swab data to evaluate person-level and facility-level characteristics associates with MDRO carriage.The overall prevalence of MDROs in the 21 facilities was 67%, with at least one MDRO found in 65% of NH residents and 80% of LTAC residents. Twenty-seven percent of NH residents and LTAC patients were found to carry multiple MDRO pathogens. The most common MDROs in NHs were MRSA (42%) and ESBL (34%); in LTACs they were VRE (55%) and ESBL (38%). MDRO status was known for only 18% of NH residents and 49% of LTAC patients. Multivariable models indicated that history of MRSA (odds ratio [OR], 1.7; 95% confidence interval [CI], 1.2 to 2.4, P = 0.04), VRE (OR 2.1; 95% CI, 1.2 to 3.8, P = 0.01), ESBL (OR, 1.6; 95% CI, 1.1 to 2.3, P = 0.03) and diabetes (OR, 1.3; 95% CI, 1.0 to 1.7, P = 0.03) were associated with any MDRO carriage."In summary, MDRO colonization prevalence is high within the NH and LTAC setting, far exceeding published reports in acute care hospitals. These data demonstrate the importance of NH/LTACs as a dominant MDRO reservoir in the healthcare system," the authors of the study write. "Investment in universal strategies of infection prevention and antimicrobial stewardship that are applicable to nursing homes and long term acute care hospitals are greatly needed and arguably overdue."Feb 11 Clin Infect Dis abstractlast_img read more

Lady Mariners Hoping For The best

first_img Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant)center_img Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) With a week to go, local softball teams are involved in a mad scramble to earn playoff berths, with Westhampton, Hampton Bays, Southampton, and East Hampton all playing make or break games.It’s been years since the Lady Bonackers and Lady Mariners faced off in a make or break softball game, and last Friday both teams delivered for the loyal fans that have waited so long.Yes, the Lady Mariners, playing at home, emerged victorious, by the slimmest of margins, a 1-0 score. But there were only winners on the field on this day.Sam Wesnofske, Southampton’s senior all-star pitcher, turned in a superhuman effort against East Hampton, going the distance and striking out 17 batters. Caroline Wetter’s single in the fourth drove in Stella Schoenberg for the only run of the game.It was only one of the nail biters contested last week in what has become one of the most competitive seasons ever for East End teams.Southampton, like so many of the tightly bunched teams in the 24-team League VII, wants a playoff berth. The Lady Mariners took an important step on May 3, knocking off Westhampton 6-5.Leah Sellinger hit a walk-off single to score Emma Wesnofske and lead Southampton in Suffolk VII. The always reliable Wesnofske struck out 13 and also went yard twice. Sellinger hit a walk-off single to score Emma Wesnofske with the winning run.The two wins upped Southampton’s record to 9-6 — good enough for a playoff berth? Not necessarily. Section 11, the governing body of public high school athletics, instituted a ratings system similar to one used in football. Southampton did not catapult ahead of the Lady Hurricanes in the point system despite the victory. It uses weighted averages and strength of opponents to choose those teams most deserving of a playoff berth. It is deeply flawed. Just ask coach Tania Ciancino if the Lady Mariners are denied a spot.Westhampton, playing at home crushed 12-0 on May 2 in a must-win game. Lauren Ramos went 3-for-4 and McKinley Skala went 3-for-3 to lead Westhampton in Suffolk VII. Angie Acampora struck out eight in a five-inning one-hitter.Westhampton, despite an inferior 7-7 won-lost record, has a rating of 134.8, and as of the last calculations provided by Section 11, Southampton sits at 113.7. Both teams are in Class A, and there may not be room for both in the playoffs, which begin May 14.That’s because Hampton Bays (9-6, 129.6 rating) defeated Southampton, 5-3, at Red Creek Park on May 1. Then, they pulled out a critical victory three days later when Amelia Kozuchowski’s two-out base hit drove in Katie Picataggio with the winning run against Islip. Hampton Bays had a tough encounter at East Islip on May 8 and finishes at Mercy on May 11. Even with two losses, Hampton Bays may be sitting in the catbird seat.Southampton played Hauppauge (11-5) at home on May 8 and plays Rocky Point (5-10) on May 11 and travels to Bayport/Blue Point (2-8) on May 10. All the games are slated to begin at 4:30 PM.The clock has finally run out on East Hampton. The locals have two home games left, May 10 versus East Islip and May 11 against Mattituck (4:30 PM).Riverhead, a Class AA team competing in League II, has lost three in a row. On May 2, the Lady Waves lost a heartbreaker at Bayshore 3-2. Sachem beat the locals 6-2 a day earlier.The Waves (3-5) have three games left as of this writing: at home against Whitman (7-4) on May 7 and Northport May 10, and at Lindenhurst (6-3)(0-9) on May [email protected] Share Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant) Southampton, NY – 5/4/18 – Southampton Varsity softball vs. East Hampton in Southampton, NY May 4, 2018. (Photo by Gordon M. Grant)last_img read more

Mike Sorensen: It’s time for the NBA to move the 3-point line back to 25 feet or beyond

first_imgSALT LAKE CITY — I’ve been a fan of basketball’s 3-point line ever since the days of the old American Basketball Association, which pioneered its use back in the 1960s and ‘70s when the old Utah Stars played in the league.In fact, back in high school, my friends and I even organized our own “ABA League” with our own teams and names (I was Mel Daniels of the Indiana Pacers) using a local elementary school as our home court with 8-foot baskets where dunks were plentiful. We also had 3-point baskets, made possible by the lines we spray-painted on the blacktop (sorry about that, Indian Hills Elementary, please forgive us).It took until 1979, three years after the demise of the ABA, for the NBA to adopt the 3-point line at 23 feet, 9 inches and 22 feet from the corners, and it took quite a while for teams to embrace the new concept. For instance in 1979-80, the first year of the 3-point shot, an average of only three 3-pointers were taken per game and one team, the Atlanta Hawks, averaged less than one try per game. A decade later, the NBA average was only up to seven 3-pointers per game.An ESPN writer named Kirk Goldsberry has written the book “SprawlBall: A Visual Tour of the New Era of the NBA,” which includes a lot of discussion about the proliferation of 3-point shooting. He shares this astonishing statistic: This past season NBA players made 4,000 more 3-point shots (27,955) than they made during the entire decade of the 1980s (23,871).In those early years, NBA teams still stuck to the longtime basketball principle of working the ball close to the basket for a shot. By the mid-1990s, the NBA encouraged the long ball by moving the line closer to the basket (22 feet all the way around) over a three-year period before moving it back.However, thanks in large part to the recent analytics boom that each NBA franchise now employs, 3-point shooting has gone bonkers. It seems simple, but as long as you’re making more than 33.3 percent of your 3-pointers that beats making less than 50 percent of your 2-point shots. This season, every team but one — the Phoenix Suns at 32.9 percent — exceeded that threshold.The two teams that have exploited the 3-point shot more than any other are the Houston Rockets and the Golden State Warriors. In Saturday night’s Rockets-Warriors game, the two teams combined for 75 3-point attempts among the 188 total shots they put up. While that seems like a lot, it was a pretty average night of 3-point shooting for those two teams. Back in mid-January, the Rockets and Brooklyn Nets combined for a ridiculous 106 3-point attempts, with the Rockets attempting 70 of them, smashing the previous record.Three-point numbers have really shot up the past five years from around 20 per game per team up to around 34 per team per game.I remember interviewing Quin Snyder a few years ago about 3-point shooting before the recent surge and him telling me he was OK with more 3-pointers, but wasn’t a fan of players hopping backward behind the line in order to take a 3. Nowadays everyone is going backward to shoot 3-pointers and most coaches are more than happy for their teams to do so. The worst shot is that 22-foot 2-pointer just inside the arc.The one outlier in all this 3-point madness is San Antonio Spurs coach Gregg Popovich, who admits he “hates” the 3-pointer and has said, “I don’t think it’s basketball. I think it’s kind of like a circus sort of thing.” No surprise, his team shoots fewer 3-pointers than any other in the league at 25.3 per game, about half as many as league leader Houston (45.4).However, it’s interesting to note that the Spurs were No. 1 in the league this past season in 3-point percentage (39.2), followed by the Clippers (38.8 percent), who ranked third in fewest attempts. So perhaps there is a case to be made that quality 3-point shots are as smart as a huge volume of 3-pointers.In his book, Goldsberry has some ideas on slowing down the 3-point explosion, including moving the line back each year depending on results from the previous year. One of his ideas, which even he calls crazy, is to let each team make its own 3-point line, much like baseball teams have their own ballpark dimensions with different distances for home-run fences.Here’s what I’d like to see happen:Move the line back to an even 25 feet. That’s just 1 foot and 3 inches longer than the current distance. With the court measuring 50 feet wide, that means that the arc would run into the sideline before the baseline, eliminating those corner 3s where, as Goldsberry puts it, players “are just standing around picking dandelions like little league right fielders.”With the line moved back slightly, that would eliminate a few guys who shouldn’t be trying 3-pointers, open up even more space around the basket and force players to perfect the midrange jumpers that have pretty much disappeared from today’s NBA game. It would give fans more variety to watch, some 15- and 20-footers mixed in with all the dunks and 3-point shots.Remember a little over a decade ago, college basketball moved its line back a foot to the current 20 feet, 9 inches and most would agree it’s opened up the floor more and made for a better game on the collegiate level.Some might see a longer arc as a negative but great shooters like Steph Curry and Damian Lillard, who already shoot from outlandish distances, would be rewarded. Meanwhile 7-footers such as Joel Embiid and Nikola Jokic, who ranked near the bottom of the NBA at 30 percent from 3 this year, might stay closer to the basket where they belong. NBA rules have adapted over the years to make the game more fun for players, fans Relatedlast_img read more


first_img(REOPENS DEL 41) (REOPENS DEL 41) For left-armer Mills, who bowls at 90 mph, what got RCB going was the search for a replacement for Mitchell Starc, who pulled out of the IPL yesterday. “Bangalore has a very small ground. It favours batsmen — the average first innings score was 199, and second innings was 190 and therefore, we really needed bowlers, especially with Mitchell Starcs unavailability this edition, and therefore Tymal Mills was a great buy. He suits the playing conditions in Bangalore,” RCB chairman Amrit Thomas told reporters. Mumbai Indians owner Nita Ambani said that her team was not disappointed despite going deep into the bidding battle for both Stokes and Mills. “When you enter an auction, you leave disappointment outside the room as there isnt a straight forward strategy. We always have back up strategies. We are not disappointed. We are very happy with the players we have,” she said. On buying India discard Karn Sharma for Rs 3.2 crore, Ambani said: “We needed a leg-spinner.” Among notable international players, New Zealand all-rounder Corey Anderson and Sri Lankan Test captain Angelo Mathews were picked up by Delhi Daredevils at their base price of Rs 1 Crore (USD 150,000)and Rs 2 crore (USD 300,000) respectively. Daredevils also bought South African paceman Kagiso Rabada for Rs 5 crore after some bidding. New Zealand fast bowler Trent Boult was picked by KKR at Rs 5 crore (USD 750,000). PTI BDN KHS PM PMlast_img read more

The Oklahoma State-Iowa State Game in One Infographic

first_imgOSUvISU While you’re here, we’d like you to consider subscribing to Pistols Firing and becoming a PFB+ member. It’s a big ask from us to you, but it also comes with a load of benefits like ad-free browsing (ads stink!), access to our premium room in The Chamber and monthly giveaways.The other thing it does is help stabilize our business into the future. As it turns out, sending folks on the road to cover games and provide 24/7 Pokes coverage like the excellent article you just read costs money. Because of our subscribers, we’ve been able to improve our work and provide the best OSU news and community anywhere online. Help us keep that up.AdChoices广告last_img read more